Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis M Schang

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Expert Review of Anti-Infective Therapy|December 22, 2006
First demonstration of the effectiveness of inhibitors of cellular protein kinases in antiviral therapyLuis M Schang
Mbio|January 4, 2018
Timing Is EverythingLuis M Schang
The Journal of Antimicrobial Chemotherapy|December 4, 2002
Cyclin-dependent kinases as cellular targets for antiviral drugsLuis M Schang
Expert Review of Anti-Infective Therapy|May 28, 2005
Discovery of the antiviral activities of pharmacologic cyclin-dependent kinase inhibitors: from basic to applied scienceLuis M Schang
Progress in Cell Cycle Research|November 5, 2003
The cell cycle, cyclin-dependent kinases, and viral infections: new horizons and unexpected connectionsLuis M Schang
Biochimica Et Biophysica Acta|March 17, 2004
Effects of pharmacological cyclin-dependent kinase inhibitors on viral transcription and replicationLuis M Schang
Current Pharmaceutical Design|April 14, 2006
Herpes simplex viruses in antiviral drug discoveryLuis M Schang
Expert Review of Anti-Infective Therapy|October 28, 2024
The opportunities and challenges of epigenetic approaches to manage herpes simplex infectionsSarah M Saddoris, Luis M Schang
Journal of Virology|December 17, 2009
During lytic infections, herpes simplex virus type 1 DNA is in complexes with the properties of unstable nucleosomesJonathan J Lacasse, Luis M Schang
Journal of Virology|May 3, 2014
A small molecule inhibits virion attachment to heparan sulfate- or sialic acid-containing glycansChe C Colpitts, Luis M Schang
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Expert Review of Anti-Infective Therapy|December 22, 2006
First demonstration of the effectiveness of inhibitors of cellular protein kinases in antiviral therapyLuis M Schang
Mbio|January 4, 2018
Timing Is EverythingLuis M Schang
The Journal of Antimicrobial Chemotherapy|December 4, 2002
Cyclin-dependent kinases as cellular targets for antiviral drugsLuis M Schang
Expert Review of Anti-Infective Therapy|May 28, 2005
Discovery of the antiviral activities of pharmacologic cyclin-dependent kinase inhibitors: from basic to applied scienceLuis M Schang
Progress in Cell Cycle Research|November 5, 2003
The cell cycle, cyclin-dependent kinases, and viral infections: new horizons and unexpected connectionsLuis M Schang
Biochimica Et Biophysica Acta|March 17, 2004
Effects of pharmacological cyclin-dependent kinase inhibitors on viral transcription and replicationLuis M Schang
Current Pharmaceutical Design|April 14, 2006
Herpes simplex viruses in antiviral drug discoveryLuis M Schang
Expert Review of Anti-Infective Therapy|October 28, 2024
The opportunities and challenges of epigenetic approaches to manage herpes simplex infectionsSarah M Saddoris, Luis M Schang
Journal of Virology|December 17, 2009
During lytic infections, herpes simplex virus type 1 DNA is in complexes with the properties of unstable nucleosomesJonathan J Lacasse, Luis M Schang
Journal of Virology|May 3, 2014
A small molecule inhibits virion attachment to heparan sulfate- or sialic acid-containing glycansChe C Colpitts, Luis M Schang
Pageof 6